Published on in Vol 2 , No 1 (2016) :December

Using Technology to Identify Risk and Meet Demands: An Innovative Clinical Pathway

Using Technology to Identify Risk and Meet Demands: An Innovative Clinical Pathway

Using Technology to Identify Risk and Meet Demands: An Innovative Clinical Pathway

Authors of this article:

Sally Bradford 1, 2 Author Orcid Image ;   Debra Rickwood 1, 2 Author Orcid Image

Poster

1Center for Applied Psychology, Faculty of Health, University of Canberra, Canberra, Australia

2headspace National Youth Mental Health Foundation, Melbourne, Australia

*all authors contributed equally

Corresponding Author:

Sally Bradford, PhD

Center for Applied Psychology

Faculty of Health

University of Canberra

College St Bruce

Canberra, 2617

Australia

Phone: 61 0424355895

Fax:61 2 6201 5753

Email: sally.bradford@outlook.com


Background: Over the past decade, there has been a significant push by the Australian government to fund youth-friendly mental health services that are non-stigmatizing, low cost, and accessible. One such organization is headspace: the National Youth Mental Health Foundation. This initiative has been highly successful; unfortunately, workforce and funding resources have not been able to keep up with the ever-growing demand, resulting in increasingly lengthy wait times for young people.

Objective: The aim was to investigate how technology could be integrated into current pathways of care to reduce wait times for young people accessing headspace centers and to help identify those young people at greatest risk. Objectives were to understand current clinical pathways, determine the technological requirements needed to ensure seamless integration, identify indicators of risk that highlight those young people in greatest need for immediate care, and develop a new clinical pathway that seamlessly incorporates the new technology.

Methods: An electronic holistic psychosocial assessment tool (EhHAT) was developed in collaboration with young people and service providers, with service providers specifying “critical” items they considered most indicative of risk. Center managers were also interviewed to determine current and potential pathways of care and technological requirements. The EhHAT was then administered to 151 young people attending a headspace center to determine the “critical items” most likely to identify the top 10%-20% of young people at greatest risk of harm.

Results: The critical items considered most indicative of risk included but were not limited to a suicide screen score ≥10, current homelessness, self-harming behaviors in the previous month, psychotic experiences in the previous month, daily use of drugs, and an extreme K10 score. After administering the ehHAT to young people, it was found that the suicide screen would positively identify the top 11.9% of young people most at risk. In addition to those already identified via the suicide screen, a further 13.24% would be identified as “at risk” by endorsing 3 or more “critical” items or a further 5.29% identified by endorsing 4 or more items. Interestingly, while 23.07% of participants who endorsed 3 or more critical items also had a suicide screen of ≥10, 72.72% of those who endorsed 4 or more items also had a suicide screen of ≥10. In order to ensure seamless integration into clinical pathways, technological requirements included the ability to complete the assessment via mobile, tablet or computer, automated risk alerts to clinicians via text, clear highlighting of risks to clinicians via a summary, and the ability to integrate this assessment into current client data management tools.

Conclusions: With appropriate considerations and adaptations, technology can be integrated into clinical pathways to assess young people before they see a clinician. Such assessment ensures young people at the greatest risk of harm receive care quickly. Furthermore, the early identification of those with milder symptoms allows young people to be re-directed to alternative treatment options. Utilizing this stepped care approach will reduce wait times for those with more severe symptomology and those at greatest risk of harm.

iproc 2016;2(1):e39

doi:10.2196/iproc.6043

Keywords


Multimedia Appendix 1

Poster.

PDF File (Adobe PDF File), 138KB

Edited by T Hale; submitted 29.05.16; peer-reviewed by CHS Scientific Program Committee, H Bridgman; accepted 02.08.16; published 30.12.16

Copyright

©Sally Bradford, Debra Rickwood. Originally published in Iproceedings (http://www.iproc.org), 30.12.2016.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in Iproceedings, is properly cited. The complete bibliographic information, a link to the original publication on http://www.iproc.org/, as well as this copyright and license information must be included.